Safety Outcomes and Secondary Outcomes
bleeding
EVENTS, BLEEDING
Major or clinically relevant nonmajor bleeding events were observed in 5 patients (1.9%): 2 in the short prophylaxis group and 3 in the long prophylaxis group. The difference between the groups was not statistically significant. Details are specified in 